Definition and History

  • Jürgen Drews


Immunopharmacology is a still young pharmacological and therapeutic discipline that has grown out of the increasingly more closely interconnected “classical” fields of immunology and pharmacology. The term “immunopharmacology” has been in regular, though not necessarily precise use for about fifteen years only. To some people, immunopharmacology means the effect of pharmaceutical agents on the immune system and its functions, and where these agents come from is of little significance — they may be endogenous, synthetic or of microbial origin. Others tend to consider immunopharmacology as the achievement of pharmacological effects with immunological products, i.e. with antibodies, lymphokines and other factors, mostly consisting of proteins. For clinicians, on the other hand, immunopharmacology is more likely to be the basis for treatment of diseases of the immune system, particularly the autoimmune diseases and anaphylactic and atopic reactions.


Multiple Sclerosis Immune System Functional System Pharmaceutical Agent Nonsteroidal Antiinflammatory Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Herberman RB (ed) (1980): Natural cell-mediated immunity against tumors. Academic Press, New York.Google Scholar
  2. Herberman RB (ed) (1982): NK cells and other natural effector cells. Academic Press, New York. Sirois P, Rola-Pleszczynski M (eds) (1983): Immunopharmacology. Elsevier Biomedical Press.Google Scholar
  3. Sirois P, Rola-Pleszczynski M, Oxford (eds) (1983): Immunopharmacology. Elsevier Biomedical Press. Amsterdam, New York, Oxford (Research Monographs in Immunology, Vol 4.)Google Scholar
  4. Wechter W, Longhman B (1984): Immunology in drug research. Progress in Drug Res Vol 28, 233–272. Birkhäuser, Basel.Google Scholar
  5. Hibbs JB, Granger DL, Cook JL, Lewis AM (1983): Activated macrophage mediated cytotoxicity for transformed target cells. In: Mechanisms of cell-mediated cytotoxicity ( Clark WR, Golstein P, eds), Plenum Press, New York and London, 315–335.Google Scholar
  6. Key ME, Hoyer L, Bucana C, Hanna MG (1982): Mechanisms of macrophage-mediated tumor cytolysis. In: Mechanisms of cell-mediated cytotoxicity ( Clark WR, Golstein P, eds). Plenum Press, New York and London, 265–310.Google Scholar
  7. Kohler PF (1982): The autoimmune diseases. JAMA, Vol 248, No 20, 2646–2656.PubMedCrossRefGoogle Scholar
  8. Schultz RM, Chirigos MA (1980): Macrophage activation for nonspecific tumor cytotoxicity. Advances in Pharmacology and Chemotherapy, Vol 17, 157–193.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • Jürgen Drews
    • 1
  1. 1.F. Hoffmann-La Roche Ltd.BasleSwitzerland

Personalised recommendations